Why the study?
Does minoxidil reduce blood pressure in azotemic patients with severe resistant hypertension?
Does minoxidil reduce blood pressure in azotemic patients with severe resistant hypertension?
Minoxidil effectively lowers blood pressure in azotemic patients with severe resistant hypertension, though it is associated with significant adverse events and disease progression.
Answers are grounded in this paper and cite their sources.
Minoxidil may lower BP in azotemic resistant hypertension; leaves open renal safety and efficacy in controlled trials.
Twenty-seven azotemic patients with severe hypertension resistant to the usually employed antihypertensive drugs received from 5 to 60 mg of minoxidil daily in combination with other antihypertensive drugs for 3 days to 144 weeks. At the time minoxidil treatment began, the mean age of the 27 was 44 (range, 16–65) years; 18 were black, and 18 were men. Their serum creatinine levels averaged 6.4 mg/dl (range, 1.7–17.1). Fifteen had hemorrhages and/or exudates in their ocular fundi, and 6 were being hemodialyzed. After 1 month of minoxidil treatment the average fall in supine blood pressure was 27/23 mm Hg. From the last value before minoxidil to the last value during minoxidil, an average of 40 weeks, the serum creatinine concentration rose an average of 0.8 mg/dl. For the 19 patients who were never dialyzed, the increase averaged 1.1 mg/dl, and for the 8 patients who were dialyzed, there was a decrease of 0.2 mg/dl. Eleven patients discontinued minoxidil after 3 days to 35 weeks: 3 because their hypertension was controlled with other drugs during dialysis: 2 after nephrectomies because their blood pressure could not be controlled; 1 following renal transplantation; 1 each because of hirsuitism, massive congestive heart failure, and hypotension; and 2 because of refusal to continue the regimen or moving out of the area. Four patients died on minoxidil: 2 from end-stage renal disease after 4 and 17 weeks, 1 from bronchopneumonia after 3 days, and 1 with a previous history of myocardial infarction from acute cardiorespiratory arrest after 3 weeks.
No takes yet. Share an insight, caveat, or question.
Camel et al. (1980) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: